‘Rplate’™ – rapid antibiotic susceptibility test

A rapid, low cost, antibiotic susceptibility test for urinary tract infections

• Rapid time to result (TTR) (< 30m)
• Mass-manufacturable, platform
• High sensitivity and repeatability
• Affordable price

Technology:
  • Antimicrobial stewardship
  • Microbial diagnostics
  • Infection prevention
  • Antimicrobial compound/strategy
  • Removal antibiotics/bacteria

Microorganisms:
  • Bacteria
  • Fungi
  • Viruses
  • Yeasts
  • Parasites

Application:
  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Development
  • Research
  • Validation
  • Market entry
  • Marketed product

Organization:
  • Company
  • Academia
  • Institute
  • NGO
  • Government

Partnering:
  • Co-develop
  • License
  • Outsource
  • Joint Venture
  • Sell

Funding organisation:
  • OTHER / NA
  • CARB-X
  • FIND
  • GARDP
  • REPAIR

Infectious disease area:
  • UTI
  • BSI
  • RTI
  • STI
  • GII
  • SSTI
  • CNSI
  • IAI
  • SSI

Geographic origin:
  • Eurasia
  • North America
  • South America
  • Africa
  • Oceania


Global commercilisation partner – large/medium-sized IVD company to negotiate a deal where our partner would be responsible for sales, marketing, technical support and regulatory approval in the agreed territory, whether global or regional

Spinout company from the University of Strathclyde, Glasgow, UK

In time, we will expand the product platform to tackle not only UTIs, but other infections including systemic sepsis, respiratory tract infections, meningitis and systemic fungal infections etc


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed